Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VENS: Vitamin E in Non-Diabetic NASH
NCT02962297Completed
- Sponsor
- Zhejiang Medicine Co., Ltd.
- Start
- Dec 2016
- Primary completion
- Nov 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial in Nonalcoholic steatohepatitis (NASH) comparing Vitamin E Group with Placebo Group (2 arms). Primary endpoint: Improvement in hepatic histology at 96 weeks. Started Dec 2016; status: completed.
02
Drugs
vitamin e
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02962297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962297.